SkinBit Is a Skin Cancer Screening Technology Built on Tracking Change
SkinBit is a skin cancer screening technology that images the entire body and lets dermatologists track changes year over year.
Photo source:
SkinBit
SkinBit Is a Skin Cancer Screening Technology Built on Tracking Change
Spotting
a dangerous mole usually depends on someone noticing it changed, which requires
remembering exactly what it looked like the last time anyone checked. SkinBit
describes itself as bringing together three things dermatology has rarely had
in one place: the whole skin surface, captured in close-up detail, tracked
consistently over time. The company built its skin cancer screening technology
around a scanning system that images a person's entire visible skin surface,
with every scan reviewed by a dermatologist. SkinBit is currently taking
waitlist signups ahead of opening locations across the United States.
Capturing Detail the Eye Alone Misses
SkinBit's
imaging runs through high-resolution photography combined with cross-polarized
light, a technique the company states cuts surface glare to reveal fine detail
invisible to the naked eye. A scan captures the full exposed skin surface
across fifteen anatomical regions in a single pass, under controlled lighting,
rather than a clinician selectively photographing a handful of spots that
happen to look concerning that day. Alongside the images themselves, SkinBit
records structured metadata for each mark: its anatomical location, dimensions,
and specific characteristics, building a detailed record rather than a simple
photo album.
Why the Second Visit Matters More Than the First
SkinBit's
Chief Medical Officer, Dr. Sancy Leachman, describes a lesion's change over
time as the highest-signal data available in dermatology, and the company's
entire design is built around making that comparison the default rather than
something only offered to high-risk patients with an especially attentive
doctor. At every return visit, a dermatologist reviews that day's images
against the prior year's scan side by side, mark by mark, rather than relying
on memory or a general visual impression of whether something looks different.
Where Software Helps and Where a Person Decides
SkinBit
is specific about dividing labor between its technology and its clinicians.
Computer vision helps organize the large set of images a full-body scan
produces and presents year-over-year comparisons in a consistent order for
review, but the company states plainly that its dermatologists read every scan
and make every recommendation themselves. Each identified mark is assigned one
of three outcomes by a board-certified dermatologist: routine monitoring, more
frequent monitoring, or referral for a biopsy. Results are delivered within 48
hours in a report designed to be shared with a person's own dermatologist, and
the scan itself takes place in a private room, covered or uncovered at the
person's own preference. SkinBit's membership structure provides unlimited
scans alongside dermatologist review and long-term tracking.
A Deliberately Separated Structure
SkinBit's
own site is direct about what the technology does and doesn't do: the imaging
system documents the surface of a person's skin and is not intended to
diagnose, treat, cure, or prevent any disease, with actual screening and
diagnosis performed only by a licensed dermatologist. The company also
separates its business structure accordingly, stating that SkinBit, Inc.
provides the imaging technology itself, while clinical services are delivered
through separate, independently owned physician practices rather than SkinBit
practicing medicine directly. That structure is paired with a named medical
advisory group whose members hold roles including chief of medical dermatology
at a major academic hospital and chief medical officer positions tied to skin cancer
research, lending the imaging protocol real clinical input rather than being
designed by engineers alone.
You have exceeded your free limits for viewing our premium content
Please subscribe to have unlimited access to our innovations.
Get The Latest In Innovation
Join Our Newsletter
Where bold ideas find bold readers.
